Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 14/20 | 0.66 |
| ▸ | DDR2 | Q16832 | 2/20 | 0.62 |
| ▸ | MAPK13 | O15264 | 4/20 | 0.61 |
| ▸ | MAPK12 | P53778 | 4/20 | 0.61 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.61 |
| ▸ | CNR1 | P21554 | 1/20 | 0.58 |
| ▸ | CNR2 | P34972 | 1/20 | 0.58 |
| ▸ | TNF | P01375 | 2/20 | 0.55 |
| ▸ | CIT | O14578 | 1/20 | 0.55 |
| ▸ | MUSK | O15146 | 1/20 | 0.55 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.55 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.55 |
| ▸ | STK10 | O94804 | 1/20 | 0.55 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.55 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | RAF1 | P04049 | 1/20 | 0.55 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.55 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10130085 | 0.92 | MAPK14 (0.66) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL593011 | 0.89 | MAPK14 (0.60) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL10158410 | 0.88 | MAPK14 (0.64) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL594196 | 0.88 | DDR2 (0.68) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL10130103 | 0.88 | CNR1 (0.73) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL10129913 | 0.85 | MAPK14 (0.76) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL30449051 | 0.85 | MAPK14 (0.68) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL6334316 | 0.85 | MAPK14 (0.68) | MAPK14DDR2MAPK13MAPK12MAPK11 | |
| SCHEMBL11753102 | 0.85 | RXFP1 (0.59) | MAPK14MAPK13MAPK12MAPK11KDR | |
| SCHEMBL4566793 | 0.84 | MAPK14 (0.66) | MAPK14DDR2MAPK13MAPK12MAPK11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114873-B2 | 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase | ARQULE, INC. (US) | 2012-02-14 | — | — | US | disclosed |
| US-20100311754-A1 | 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase | ARQULE, INC. (US) | 2010-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100311754-A1 | 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase | MAPK1, MAPK7, MAP3K1 | MAPK14 15/4885DDR2 3028/4885MAPK13 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.